Skip to content
lifestyle.phenomena.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Sanofi Winthrop Industrie
Press Release: Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia
June 23, 2026
Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses
June 23, 2026
Press Release: Sanofi appoints Paulo Fontoura as Global Head of R&D
June 22, 2026
Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma
June 19, 2026
Press Release: Sanofi launches 2026 global employee stock purchase plan
June 4, 2026
Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease
May 28, 2026
Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD
May 18, 2026
Press Release: Annual General Meeting of April 29, 2026 – Belén Garijo appointed as Director and Chief Executive Officer of Sanofi
April 29, 2026
Press Release: Sanofi successfully prices 2.3 billion of bond issue
April 24, 2026
Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses
April 24, 2026
1
2
3
4
Next Page
→